Lockheed's Q3 Beat and DoD Agreements Boost Demand Visibility, but Valuation Remains Full
Read source articleWhat happened
Lockheed Martin reported a Q3 beat-and-raise, with management also announcing long-term procurement agreements with the Department of Defense, which likely addresses the funding uncertainty around PAC-3 and other missile programs. This news drove a rally in October, reducing the risk that near-term missile orders slip beyond FY2026 appropriations. However, the stock already traded at 21.4x earnings prior to this news, and the rally likely pushes the valuation closer to the trim threshold of $650. The master report's bear case of PAC-3 slippage and execution charges becomes less likely, but the bull case of clean conversion and margin expansion still needs confirmation. Overall, the fundamental picture improves, but the market appears to have priced in much of the good news, leaving limited upside from current levels.
Implication
The beat-and-raise and procurement agreements lower the probability of the bear scenario (PAC-3 slippage and execution charges) and support the base case of $605, but the stock's rally likely already reflects this good news. The key monitor remains whether the procurement agreements include funded PAC-3 awards and whether MFC margins stay above 14% in coming quarters. Aeronautics charges must also stop recurring; otherwise, the missile upside may be offset by execution losses. Until those conditions are confirmed and valuation becomes more attractive, a patient approach is warranted. Investors can add on dips below $580 and trim above $650, given the limited risk-reward at extremes.
Thesis delta
The Q3 beat-and-raise and long-term DoD procurement agreements reduce the risk of a PAC-3 award slip and strengthen the demand visibility for missiles. However, the stock's rally likely prices in much of this improvement, keeping valuation stretched at above 21x earnings. Therefore, the thesis shifts from WAIT with a bias to trim above $650 to a more balanced WAIT with a tighter range, acknowledging reduced downside but limited upside at current levels.
Confidence
Moderate